Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.47 USD | +9.38% | +27.03% | -75.90% |
Mar. 28 | Transcript : Agile Therapeutics, Inc., Q4 2023 Earnings Call, Mar 28, 2024 | |
Mar. 28 | Earnings Flash (AGRX) AGILE THERAPEUTICS Posts Q4 Revenue $3.6M | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration1st Jan change | Capi. | |
---|---|---|
-75.90% | 2.95M | |
-3.18% | 102B | |
+1.49% | 96.29B | |
+2.13% | 22.18B | |
-15.82% | 21.2B | |
-9.21% | 18.31B | |
-39.98% | 17.38B | |
-14.47% | 16.36B | |
+4.55% | 13.97B | |
+32.37% | 12.17B |
- Stock Market
- Equities
- AGRX Stock
- News Agile Therapeutics, Inc.
- Agile Therapeutics : Oppenheimer Adjusts Agile Therapeutics' Price Target to $6 From $10, Maintains Outperform Rating